His primary areas of study are Intensive care medicine, Antibiotics, Methicillin-resistant Staphylococcus aureus, Internal medicine and Antibiotic resistance. The concepts of his Intensive care medicine study are interwoven with issues in Bacteremia, Hygiene, Public health and Emergency medicine. Microbiology covers Stéphan Juergen Harbarth research in Antibiotics.
His Methicillin-resistant Staphylococcus aureus study combines topics in areas such as Carriage, Staphylococcal infections and Infection control. His Internal medicine research includes elements of Surgery and Intensive care. His Antibiotic resistance research focuses on Drug resistance and how it connects with Antimicrobial, Biotechnology, Mortality trends and Social determinants of health.
Stéphan Juergen Harbarth mainly focuses on Intensive care medicine, Internal medicine, Antibiotics, Methicillin-resistant Staphylococcus aureus and Infection control. The Intensive care medicine study combines topics in areas such as Epidemiology, Sepsis and Hygiene. His Internal medicine study incorporates themes from Carriage and Surgery.
His research related to Antibiotic resistance and Antibacterial agent might be considered part of Antibiotics. His Antibiotic resistance research is multidisciplinary, relying on both Antimicrobial and Drug resistance. His research in Infection control intersects with topics in Transmission, Outbreak and Public health.
Stéphan Juergen Harbarth focuses on Internal medicine, Antibiotics, Antibiotic resistance, Psychological intervention and Intensive care medicine. His work carried out in the field of Internal medicine brings together such families of science as Carriage and Cephalosporin. His Antibiotics study necessitates a more in-depth grasp of Microbiology.
Stéphan Juergen Harbarth has researched Antibiotic resistance in several fields, including Drug resistance and Public relations. Stéphan Juergen Harbarth studies Intensive care medicine, focusing on Infection control in particular. His study in Infection control is interdisciplinary in nature, drawing from both Hygiene and Emergency medicine.
Internal medicine, Antibiotics, Intensive care medicine, Antibiotic resistance and Psychological intervention are his primary areas of study. His studies deal with areas such as Carriage and Intensive care as well as Internal medicine. His study focuses on the intersection of Antibiotics and fields such as Colonization with connections in the field of Polymerase chain reaction.
His Intensive care medicine research includes themes of Essential medicines, Health care, Outbreak, Evidence-based practice and Coronavirus disease 2019. His studies in Antibiotic resistance integrate themes in fields like Medical microbiology, Point-of-care testing, Drug resistance and Infectious disease. His Psychological intervention research is multidisciplinary, incorporating elements of Institutional repository, Antimicrobial stewardship, Family medicine, Emergency medicine and Risk analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A-P Magiorakos;A Srinivasan;R B Carey;Y Carmeli.
Clinical Microbiology and Infection (2012)
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
Didier Pittet;Stéphane Hugonnet;Stephan Harbarth;Philippe Mourouga.
The Lancet (2000)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth.
Lancet Infectious Diseases (2017)
DIAGNOSTIC VALUE OF PROCALCITONIN, INTERLEUKIN-6, AND INTERLEUKIN-8 IN CRITICALLY ILL PATIENTS ADMITTED WITH SUSPECTED SEPSIS
Stephan Harbarth;Katarina Holeckova;Céline Froidevaux;Didier Pittet.
American Journal of Respiratory and Critical Care Medicine (2001)
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
Mirjam Christ-Crain;Daiana Stolz;Roland Bingisser;Christian Müller.
American Journal of Respiratory and Critical Care Medicine (2006)
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
Sara E. Cosgrove;Youlin Qi;Keith S. Kaye;Stephan Harbarth.
Infection Control and Hospital Epidemiology (2005)
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial
Vandack Nobre;Stéphan Juergen Harbarth;Jean-Daniel Graf;Peter Rohner.
American Journal of Respiratory and Critical Care Medicine (2008)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
Stéphan Juergen Harbarth;Jorge Garbino;Jérôme Pugin;Jacques-André Romand.
The American Journal of Medicine (2003)
Methicillin-Resistant Staphylococcus aureus (MRSA): Burden of disease and control challenges in Europe
Robin Köck;Karsten Becker;B. Cookson;J. E. van Gemert-Pijnen.
The preventable proportion of nosocomial infections: an overview of published reports
S Harbarth;H Sax;P Gastmeier.
Journal of Hospital Infection (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: